Combined 3D-QSAR and molecular docking study for identification of diverse natural products as potent Pf ENR inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1875-6697|11|3|245-257

ISSN： 1573-4099

Source： Current Computer - Aided Drug Design, Vol.11, Iss.3, 2015-09, pp. : 245-257

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combined 3D-QSAR, Pharmacophore and Docking Studies on Benzenesulfonamide Derivatives as Potent 12-Lipoxygenase Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 14, Iss. 1, 2017-01 ,pp. : 74-82

Bentham Science Publishers

Access to resources Recommend Favorite

3D-QSAR, Molecular Docking and Molecular Dynamics Studies of 2,4- Diarylaminopyrimidine Analogues (DAAP Analogues) as Potent ALK Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 14, Iss. 3, 2017-01 ,pp. : 270-286

Bentham Science Publishers

Access to resources Recommend Favorite

3D-QSAR and Molecular Docking Studies of Flavonoid Derivatives as Potent Acetylcholinesterase Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 12, Iss. 10, 2015-12 ,pp. : 837-7

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacophore Based 3D-QSAR Modeling and Molecular Docking of Leucettines as Potent Dyrk1A Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 10, Iss. 8, 2013-10 ,pp. : 719-726

Bentham Science Publishers

Access to resources Recommend Favorite

Toward the Identification of Novel Carbonic Anhydrase XIV Inhibitors using 3D-QSAR Pharmacophore Model, Virtual Screening and Molecular Docking Study

By  

Letters in Drug Design & Discovery, Vol. 11, Iss. 4, 2014-05 ,pp. : 403-412

Bentham Science Publishers

Access to resources Recommend Favorite